This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Bevacizumab and Bleomycin combination for treatment of orbital lymphatico‐venous malformation recalcitrant to sclerosing therapy alone. (23rd February 2018)
Record Type:
Journal Article
Title:
Bevacizumab and Bleomycin combination for treatment of orbital lymphatico‐venous malformation recalcitrant to sclerosing therapy alone. (23rd February 2018)
Main Title:
Bevacizumab and Bleomycin combination for treatment of orbital lymphatico‐venous malformation recalcitrant to sclerosing therapy alone